(132 days)
The North American Scientific Corporation's I-125 Radionuclide Brachytherapy Source Model MED3631-A is a device intended to deliver radiation by interstitial intracavity or surface application for therapy of malignant lesions.
I-125 Radionuclide Brachytherapy Source Model MED3631-A
This document is a 510(k) premarket notification letter from the FDA regarding an I-125 radionuclide brachytherapy source. As such, it does not contain the detailed information required to answer your request about acceptance criteria and a study proving device performance.
The letter approves the device based on substantial equivalence to a predicate device, meaning it was determined to be as safe and effective as a device already legally marketed. It does not provide data from a specific study designed to prove new acceptance criteria for this particular device.
Therefore, I cannot provide the requested information, which typically would be found in a clinical study report or a detailed performance validation report:
- Table of acceptance criteria and reported device performance: Not present in this document.
- Sample size used for the test set and the data provenance: Not present.
- Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not present.
- Adjudication method for the test set: Not present.
- Multi-reader multi-case (MRMC) comparative effectiveness study: Not applicable or present for this type of device (a brachytherapy source, not an AI diagnostic tool).
- Standalone (algorithm only) performance: Not applicable or present.
- Type of ground truth used: Not applicable.
- Sample size for the training set: Not applicable (no AI/machine learning involved).
- How the ground truth for the training set was established: Not applicable.
§ 892.5730 Radionuclide brachytherapy source.
(a)
Identification. A radionuclide brachytherapy source is a device that consists of a radionuclide which may be enclosed in a sealed container made of gold, titanium, stainless steel, or platinum and intended for medical purposes to be placed onto a body surface or into a body cavity or tissue as a source of nuclear radiation for therapy.(b)
Classification. Class II (special controls). A prostate seeding kit intended for use with a radionuclide brachytherapy source only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.